Garadah Taysir S, Mahdi Najat A, Jaradat Ahmed M, Hasan Zuheir A, Nagalla Das S
Cardiac Unit, Salmaniya Medical Complex, Ministry of Health, Kingdom of Bahrain. ; Department of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Kingdom of Bahrain.
Clin Med Insights Cardiol. 2013;7:21-7. doi: 10.4137/CMC.S10702. Epub 2013 Jan 28.
Thyroid gland dysfunction and echocardiographic cardiac abnormalities are well-documented in patients with transfusion dependent beta-thalassemia major (β-TM).
This cross-sectional analytic study was conducted to investigate left ventricle (LV) diastolic and systolic function using pulsed Doppler (PD) and tissue Doppler (TD) echocardiography and correlate that with serum level thyroid stimulating hormone in patients with β-TM.
The study was conducted on patients with β-TM (n = 110, age 15.9 ± 8.9 years) and compared with a control group (n = 109, age 15.8 ± 8.9 years). In all participants, echocardiographic indices of PD and TD were performed and blood samples were withdrawn for measuring the serum level of TSH, free T4, and ferritin. A linear regression analysis was performed on TSH level as the dependent variable and serum ferritin as independent. Stepwise multiple regression analysis was used to determine the odds ratio of different biochemical and echo variables on the risk of developing hypothyroidism.
Patients with β-TM compared with controls had thicker LV septal wall index (0.65 ± 0.26 vs. 0.44 ± 0.21 cm/M(2), P < 0.001), posterior wall index (0.65 ± 0.23 vs. 0.43 ± 0.21 cm/m(2), P < 0.01) and larger LVEDD index (4.35 ± 0.69 vs.3.88 ± 0.153 mm/m(2), P < 0.001). In addition, β-TM patients had higher transmitral E wave velocity (E) (70.81 ± 10.13 vs. 57.53 ± 10.13 cm/s, P = 0.02) and E/A ratio (1.54 ± 0.18 vs. 1.23 ± 0.17, P < 0.01) and shorter deceleration time (DT) (170.53 ± 13.3 vs. 210.50 ± 19.20 m sec, P < 0.01). Furthermore, the ratio of transmitral E wave velocity to the tissue Doppler E wave at the basal septal mitral annulus (E/Em) was significantly higher in the β-TM group (19.68 ± 2.81 vs. 13.86 ± 1.41, P < 0.05). The tissue Doppler systolic wave (Sm) velocity and the early diastolic wave (Em) were significantly lower in the β-TM group compared with controls with Sm, 4.82 ± 1.2 vs. 6.22 ± 2.1 mm/sec, P < 0.05 and (Em), 3.51 ± 2.7 vs. 4.12 ± 2.5 mm/sec. P < 0.05, respectively). The tricuspid valve velocity was significantly higher in β-TM patients compared with controls 2.85 ± 0.56 vs. 1.743 ± 0.47 m sec, respectively, P < 0.01). The prevalence of subclinical hypothyroidism in patients with β-TM was 15.4%, with significantly higher mean serum TSH compared with controls (6.78 ± 1.5 vs. 3.10 ± 1.02 μIU/mL, P < 0.01) and positively correlated with the serum ferritin level (r = 0.34, P = 0.014). On multiple regression analysis, the LV mass, LVEF%, and E/A ratio were not positive predictors of hypothyroidism in patients with β-TM.
We conclude that patients with β-TM had a high prevalence of subclinical hypothyroidism of 15.4%. Thyroid stimulating hormone was significantly high and positively correlated with the serum ferritin level. Echo cardiographic pulsed Doppler showed a restrictive LV diastolic pattern suggestive of severe diastolic dysfunction with preserved left ventricle systolic function.
在依赖输血的重型β地中海贫血(β-TM)患者中,甲状腺功能障碍和超声心动图心脏异常已有充分记录。
本横断面分析研究旨在使用脉冲多普勒(PD)和组织多普勒(TD)超声心动图研究β-TM患者的左心室(LV)舒张和收缩功能,并将其与血清促甲状腺激素水平相关联。
该研究针对β-TM患者(n = 110,年龄15.9±8.9岁)进行,并与对照组(n = 109,年龄15.8±8.9岁)进行比较。对所有参与者进行了PD和TD的超声心动图指标检查,并采集血样以测量血清促甲状腺激素、游离T4和铁蛋白水平。以促甲状腺激素水平为因变量、血清铁蛋白为自变量进行线性回归分析。采用逐步多元回归分析确定不同生化和超声变量对发生甲状腺功能减退风险的比值比。
与对照组相比,β-TM患者的左心室间隔壁指数更高(0.65±0.26 vs. 0.44±0.21 cm/M(2),P < 0.001),后壁指数更高(0.65±0.23 vs. 0.43±0.21 cm/m(2),P < 0.01),左心室舒张末期内径指数更大(4.35±0.69 vs.3.88±0.153 mm/m(2),P < 0.001)。此外,β-TM患者的二尖瓣E波速度(E)更高(70.81±10.13 vs. 57.53±10.13 cm/s,P = 0.02),E/A比值更高(1.54±0.18 vs. 1.23±0.17,P < 0.01),减速时间(DT)更短(170.53±13.3 vs. 210.50±19.20 m秒,P < 0.01)。此外,β-TM组二尖瓣环基底间隔处二尖瓣E波速度与组织多普勒E波速度之比(E/Em)显著更高(19.68±2.81 vs. 13.86±1.41,P < 0.05)。与对照组相比,β-TM组的组织多普勒收缩波(Sm)速度和舒张早期波(Em)显著更低,Sm分别为4.82±1.2 vs. 6.22±2.1 mm/秒,P < 0.05,Em分别为3.51±2.7 vs. 4.12±2.5 mm/秒,P < 0.05)。与对照组相比,β-TM患者的三尖瓣速度显著更高,分别为2.85±0.56 vs. 1.743±0.47 m秒,P < 0.01)。β-TM患者亚临床甲状腺功能减退的患病率为15.4%,与对照组相比,血清促甲状腺激素平均水平显著更高(6.78±1.5 vs. 3.10±1.02 μIU/mL,P < 0.01),且与血清铁蛋白水平呈正相关(r = 0.34,P = 0.014)。多元回归分析显示,左心室质量、左心室射血分数%和E/A比值不是β-TM患者甲状腺功能减退的阳性预测指标。
我们得出结论,β-TM患者亚临床甲状腺功能减退的患病率高达15.4%。促甲状腺激素显著升高,且与血清铁蛋白水平呈正相关。超声心动图脉冲多普勒显示左心室舒张模式呈限制性,提示严重舒张功能障碍,而左心室收缩功能保留。